Introduction
Neuropore Therapies is the first biopharmaceutical company of its class utilizing innovative structure-based design technology to discover therapies for Alzheimer’s Disease, Parkinson’s Disease and related neurodegenerative disorders. We have developed unique models of the protein aggregates abnormally accumulating in the brains of patients with these neurological conditions and discovered compounds that block their toxicity.
Our patented platform allows the rapid development, screening and testing of novel compounds aimed at blocking the formation of toxic aggregates and at protecting neurons. Our goal is to bring to clinical trials innovative and rational new treatments for Alzheimer’s Disease, Parkinson’s Disease and related conditions.
